1999
DOI: 10.1034/j.1399-3011.1999.00045.x
|View full text |Cite
|
Sign up to set email alerts
|

Solid‐phase total synthesis of polymyxin B1

Abstract: The total solid-phase synthesis of polymyxin B1 (PMB1) has been achieved in 20% yield using the orthogonal protecting group N-1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl-(Dde). This report demonstrates that a complex peptide macrocycle can be synthesized in high yields using solid-phase synthesis. According to MS and HPLC, the synthetic peptide was identical to the naturally occurring antibiotic.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
25
0

Year Published

2003
2003
2022
2022

Publication Types

Select...
4
2
2

Relationship

0
8

Authors

Journals

citations
Cited by 29 publications
(25 citation statements)
references
References 28 publications
0
25
0
Order By: Relevance
“…The cyclization reaction proceeded quantitatively in a high concentration (ca. 0.01 mmol/ml) solution of 1 L -16 L to yield 1 C -16 C , which were treated with HF to yield polymyxin B analogs (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16). The purity of the synthetic peptides was Ͼ97% as shown representatively in Fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…The cyclization reaction proceeded quantitatively in a high concentration (ca. 0.01 mmol/ml) solution of 1 L -16 L to yield 1 C -16 C , which were treated with HF to yield polymyxin B analogs (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16). The purity of the synthetic peptides was Ͼ97% as shown representatively in Fig.…”
Section: Resultsmentioning
confidence: 99%
“…5,6) These interactions lead to disordering of Gram-negative bacterial cell membranes, resulting in cell death. 7) Since the total solid phase synthesis of polymyxin B 1 was first reported by Sharma in 1999, 8) various polymyxin B analogs have been synthesized and evaluated for biological activity. [9][10][11][12][13][14][15][16][17] However, the structure-activity relationship of polymyxin B peptides is not understood in detail, due to the lack of extensive works employing highly pure peptides.…”
mentioning
confidence: 99%
“…Such protection provides a mechanism to yield a partially protected linear precursor amenable to cyclization (Figure 7). This has been somewhat challenging, as protected l -Dab residues are not so readily accessible, but in recent years examples such as Fmoc- l -Dab tert -Bbutyloxycarbonyl (Boc),69 Fmoc- l -Dab 1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (Dde),70 Fmoc- l -Dab 1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl (ivDde),71 Fmoc- l -Dab 4-methyltrityl (Mtt),72 and Fmoc- l -Dab 2-chlorobenzyloxycarbonyl (2-ClZ)73 have been described.…”
Section: Complete Synthesis Of Polymyxinsmentioning
confidence: 99%
“…Recently, total or semisynthesis or modifications of polymyxins was performed chemically or enzymatically, and the resulting products were effectively used for structure-function study (6,20,36,45,50,52). There is a limitation to obtaining diverse derivatives by using chemical or enzymatic approaches, however, and this limitation is related to the structural complexity of polymyxin.…”
mentioning
confidence: 99%